Altamira Therapeutics Ltd (CYTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2007 | 12-2006 | 12-2005 | 12-2004 | 12-2003 | |
| Gross Profit | 7,160 | 7,150 | 6,320 | 5,310 | 7,570 |
| Operating Expenses | 5,850 | 7,300 | 6,060 | 3,200 | 2,650 |
| Operating Income | -5,850 | -7,300 | -6,060 | -3,200 | -2,650 |
| Pre-tax Income | -5,850 | -7,300 | -6,060 | -3,200 | -2,650 |
| Net Income Continuous | -5,850 | -7,300 | -6,060 | -3,200 | -2,650 |
| Net Income | $-5,850 | $-7,300 | $-6,060 | $-3,200 | $-2,650 |
| EBITDA(a) | $-4,150 | $-5,940 | $-4,990 | $-2,090 | $-4,010 |